ABSTRACT. Iron is the most important metallic chemical element on Earth. Poisoning caused by excessive iron in humans has been associated with pulmonary diseases including neoplasms caused by inhalation of iron oxides. The involvement of iron in neurodegenerative processes has already been described. DNA alterations are induced by iron and other chemical compounds containing this metal; however, the data are controversial and the mechanism by which iron induces mutagenesis remains unknown. This study assessed in vitro iron-induced cytotoxic and genotoxic responses in an astrocytic cell line. Short-and long-term cytotoxicity and genotoxicity were evaluated with the Cell Proliferation Kit II and micronucleus test, respectively. Results indicated that the highest concentration of iron sulfate tested was cytotoxic in long-term cytotoxic assays and increased micronucleus frequency in comparison to controls. The significant cytotoxicity observed here might be due to the intrinsic ability of iron to induce apoptosis and possible changes in cell cycle kinetics; the genotoxic effects are probably due to the oxidant properties of iron itself. This was the first study to investigate the induction of micronuclei by iron in central nervous system cells.
INTRODUCTION
Along with aluminum (Al), iron (Fe) is the most important metallic chemical element on Earth (O'Neil, 1994) . Poisoning caused by excessive Fe in humans has been associated with pulmonary diseases including neoplasms caused by inhalation of Fe oxides (Chau et al., 1993) , as well as heart and liver diseases, diabetes, and hormonal and immunological dysfunction (Salonen et al., 1992; Gardi et al., 2002; Trinder et al., 2002) . The involvement of iron in neurodegenerative processes such as Alzheimer's and Parkinson's disease (AD and PD, respectively) has been described (Smith et al., 1997; Fasano et al., 2003) . In this context, Fe oxidation induced by the Fenton reaction could lead to protein aggregation, free radical induction, and oxidative stress, common features of neurodegenerative disturbances. Interaction between Fe and proteins seems to be a crucial factor in the development or absence of neurodegenerative disorders (Rivera-Mancía et al., 2010) .
There have been many reports of DNA alterations induced by Fe and other chemical compounds containing this metal. However, the results have been controversial and the mechanism by which Fe induces mutagenicity remains unclear (Heidelberger et al., 1983; Abalea et al., 1999) . Dunkel et al. (1999) showed that iron sulfate was the least efficient iron derivate able to induce mutations in Salmonella typhimurium. Anderson et al. (2000a) reported that ferric chloride produces high levels of DNA damage in human colon cells, but little or no damage in human lymphocytes. Ferric chloride also induces little damage in human lymphocytes, while treatment with ferrous sulfate induces a dose-dependent DNA damage (Anderson et al., 2000b) .
Although Fe contamination is associated with kidney cancer (Linehan et al., 2010) and neurodegenerative diseases, studies evaluating genotoxicity in central nervous system (CNS) cells are scarce (Alexandrov et al., 2005; Lukiw and Pogue, 2007) . Therefore, the aim of this study was to assess in vitro cytotoxic and genotoxic responses induced by Fe in an astrocytic cell line (U343 MG-a). To our knowledge, this was the first study to investigate the induction of micronuclei in binucleated U343 MG-a cells.
MATERIAL AND METHODS

Chemical compounds
Iron sulfate heptahydrate (FeSO 4 .7H 2 O, CAS No. 7782-63-0) and doxorubicin (CAS No. 23214-92-8) were purchased from Sigma Chemical Co., USA, and diluted in distilled water. Stock solutions were stored at -20°C.
Cell culture
Astrocytic cell line U343 MG-a was established from a primary adult astrocytoma resection; it is p16-deficient and p53-positive (Hiyama and Reeves, 1999) and was kindly supplied by Dr. Carlos Gilberto Carlotti Jr (FMRP-USP) and Dr. Elza Tiemi Sakamoto-Hojo (FMRP-USP). Cells were grown in 1:1 (v/v) HAM F10 + DMEM (Sigma Chemical Co.) supplemented with 15% fetal bovine serum (Gibco, USA), 0.1 mg/mL kanamycin, 0.02 mg/ mL ciprofloxacin, 0.1 mg/mL streptomycin, and 99 U/mL penicillin and kept in an incubator at 37°C. Cells were subcultured 2 or 3 times a week.
Cytotoxicity and cell survival
The Cell Proliferation Kit II (XTT), a colorimetric XTT assay (Roche), was used to evaluate cytotoxicity and cell survival. For cytotoxicity tests, 5 x 10 4 cells were seeded per well on 96-well tissue culture plates. Iron sulfate (10, 20, 40, 80, 160, 320 , and 640 µg/mL) was added to each well and incubated for 24 h. A negative control containing only culture medium was also assessed. Twenty-four hours after the end of treatment, XTT was added for 3 h, according to the manufacturer protocol. Absorbance at 562 nm was measured by a spectrophotometer (Eppendorf Biophotometer). Cell survival was expressed as a percentage of untreated cells, the negative control group designated 100%. All assays were performed in triplicate. The procedure for cell survival was the same, with 0.5 x 10 4 cells and XTT addition 96 h after the end of treatment.
Micronucleus test
U343 cells were treated with iron for 24 h. After treatment, 3 µg/mL cytochalasin B (Sigma Chemical Co.) was added for another 24 h at 37°C. Cells were harvested, centrifuged for 5 min at 800 rpm and treated with 3 mL hypotonic solution (1% sodium citrate) plus 2 mL 5:1 (v/v) cold methanol:acetic acid fixative. The cells were washed twice with 5 mL 3:1 (v/v) cold methanol:acetic acid solution. Slides were prepared and stained in a solution of 5% Giemsa dye (Sigma Chemical Co.) in phosphate buffer, pH 6.8, for 5 min. Micronuclei (MN) were scored in 1000 binucleated cells using criteria described elsewhere (Fenech et al., 2003) . The frequency of binucleated cells containing one or more MN was also determined. As a measure of cytotoxicity, the cytokinesis-block proliferating index (CBPI) was calculated according to the following formula: CBPI = [M1 + 2(M2) + 3(M3) + 4(M4)] / N, where M1-M4 represents the number of cells with 1-4 nuclei per 500 cells. Iron concentrations were 40, 160, and 640 µg/mL. As a positive control, doxorubicin was used at a final concentration of 0.0173 µg/mL.
Statistical analyses
Results are reported as means ± SD for 3 independent experiments (N = 3). Multiple variance analysis (ANOVA) and the post hoc Tukey test were performed. We also used a non-parametric test (Kruskal-Wallis). A value of P < 0.05 was considered to be statistically significant for all parameters. Analyses were performed in BioEstat 5.0 (Ayres et al., 2007) .
RESULTS
XTT results showed a reduction in cell survival at ≥40 µg/mL iron sulfate; however, the reduction was statistically significant (P < 0.05) only at 640 µg/mL. However, cytotoxicity 24 h after treatment was not statistically different. Table 1 shows the mean values obtained for cytotoxicity and cell survival at each concentration, in addition to the optical density values obtained by spectrophotometry. For the MN test, the only concentrations that produced over 50% cell survival (based on XTT assay results) were used.
Iron effects on central nervous system cell lines MN tests showed an increase in the frequency of micronuclei (Figure 1 ) induced by iron sulfate. Mean frequencies of MN per 1000 binucleated cells were 63, 68.7, and 87.3 for 40, 160, and 640 µg/mL, respectively. Statistical significance (P < 0.05) was observed at 640 µg/mL versus the negative control (87.3 MN/1000 versus 32 MN/1000 binucleated cells, respectively). Cells treated with doxorubicin had a mean frequency of 148.3 MN/1000 binucleated cells, which was also statistically significant (P < 0.05) when compared to the negative control. CBPI mean frequencies did not significantly differ between negative control and treated groups (Figure 2 ). 
DISCUSSION
There is a clear relationship between a higher incidence of neurodegenerative diseases and exposure to metals. This relationship is observed in industrialized countries, where the prevalence of PD and AD is high. Prolonged exposure to Al, Fe, manganese, and other metals is, therefore, a risk factor for neurodegenerative processes (Veldman et al., 1998; Ferrer, 2003) . Despite this association, few studies have assessed the cytotoxic and genotoxic effects of iron in CNS cells. This study evaluated the in vitro cytotoxic/genotoxic effects of iron in a human astrocytoma cell line (U343 MG-a). Our hypothesis was that Fe, due to its oxidative properties, induces cytotoxicity and genotoxicity in CNS cells, contributing to the development of neurodegenerative disorders and neoplasias. Normal CNS cells are very difficult to obtain; thus, we choose to use an established astrocytic cell line as a model.
Under our experimental conditions, Fe was unable to induce short-term cytotoxicity after 24 h. However, a long-term cytotoxic effect (cell survival in the XTT assay) was observed after 96 h. Such findings are consistent with previous reports. Lange et al. (2008) observed that an Fe(III)-salen organometallic compound had a cytotoxic effect in cell lines of ovarian adenocarcinoma (SKOV-3) at concentrations ranging from 100 nM to 1 µM. These authors also showed that Fe(III)-salen induces apoptosis. Another research group (Woldemariam and Mandal, 2008) demonstrated that Fe(III)-salen induces cytotoxicity in HEK293 cells and induces apoptosis through a mitochondrial pathway. Chow et al. (2008) reported that ferric protoporphyrin (a toxic and highly diffusible compound released from hemoglobin was cytotoxic in C6 glioma cells. Using electrophoresis and caspase detection, they observed that this effect was due to apoptosis. Even though we did not assess cell death, it is tempting to assume that the cytotoxicity observed in this study was due to apoptotic induction combined with a possible cytostatic effect.
This study showed that iron sulfate induces micronuclei in U343 MG-a cells. Consistent with these results, Prá et al. (2008) noted that ferrous sulfate induces DNA damage in peripheral blood cells and mouse bone marrow through an increase in the frequency of micronuclei. Clastogenic effects were also induced by ferrous sulfate in a micronucleus assay (Premkumar and Bowlus, 2003) in mouse bone marrow cells. The authors reported that treatment with ascorbic acid reduced the clastogenic effect of iron, probably due to its antioxidant properties. Iron can cause significant oxidative damage, inducing mutagenesis (Pierre and Fontecave, 1999) . It is likely that the clastogenic effect observed in our MN induction experiments is due to iron induction of oxidative DNA damage.
Despite the observed cytotoxic and mutagenic effects, iron sulfate did not induce changes in cell cycle kinetics, as the CBPI results were not statistically significant. However, the cytostatic effect of iron compounds was observed by others using more accurate techniques. Lange et al. (2008) observed that Fe(III)-salen delayed cell cycle progression in SKOV-3 cells. The cell cycle was evaluated by flow cytometry and the iron effect was characterized by a significant increase of S-phase cells. In another interesting study, Carlini et al. (2006) showed that iron sucrose (Fe-S) exerts a significant cytotoxic effect in bovine aortic endothelial cells. The authors stated that the effect was due to apoptosis induction and cell cycle arrest. Using immunoblot techniques, the study showed that Fe-S induces expression of p53 and p21, widely known CDK inhibitors that block the cell cycle at the G1/S checkpoint.
The cell line used in the present study has a neoplastic origin; therefore, we must be cautious in our interpretation. Nevertheless, the global portrait provided by our experiments shows that iron sulfate induces cytotoxic and genotoxic alterations in U343 MG-a cells. The significant cytotoxicity might be due to the intrinsic ability of iron to induce apoptosis along with changes in cell cycle kinetics, while the iron genotoxic effects are probably due to its oxidant properties. However, other studies should be performed to better characterize this metal genotoxic action, since it remains controversial. 
